##################################################################################
# Document Properties
##################################################################################
SET DOCUMENT Name = "32221306.bel"
SET DOCUMENT Authors = "Priya S"
SET DOCUMENT ContactInfo = "priya@causalitybiomodels.com"
SET DOCUMENT Description = "COVID Knowledge Curation project"

SET DOCUMENT Licenses = "Private Ownership to Fraunhofer Institute SCAI"
SET DOCUMENT Copyright = "Copyright Â© 2020 Fraunhofer Institute SCAI, All rights reserved"
SET DOCUMENT Version = "2.0.0"

##################################################################################
# NAMESPACES Section
##################################################################################
DEFINE NAMESPACE HGNC AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hgnc/hgnc-20190708.belns"
DEFINE NAMESPACE MGI AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mgi-mouse-genes/mgi-mouse-genes-20190128.belns"
DEFINE NAMESPACE CHEBI AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/chebi/chebi-20190708.belns"
DEFINE NAMESPACE GO AS URL 	"https://arty.scai.fraunhofer.de/artifactory/bel/namespace/go/go-20180109.belns"
DEFINE NAMESPACE TAX AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/ncbi-taxonomy/ncbi-taxonomy-20200322.belns"
#Not in template.bel
DEFINE NAMESPACE MESH AS URL 	"https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mesh/mesh-names-20181007.belns"

DEFINE NAMESPACE COVID AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/ncbi-covid19/ncbi-covid19-20200326.belns"
DEFINE NAMESPACE PUBCHEM AS PATTERN "^\d+$"
##################################################################################
# ANNOTATIONS Section
##################################################################################
DEFINE ANNOTATION Custom_CellLine AS LIST {"17cl1","HEK293/hACE"}
DEFINE ANNOTATION Virus_type AS LIST {"pseudovirion"}
DEFINE ANNOTATION concentration AS LIST {"20 nM", "100 nM"}
DEFINE ANNOTATION Treatment AS LIST {"Trypsin"}
# Document Annotations #
DEFINE ANNOTATION PublicationType AS LIST {"Research"}
DEFINE ANNOTATION PublicationStatus AS LIST {"Published"}
DEFINE ANNOTATION Section AS LIST {"Results"}

##################################################################################
# Statements #
#################################################################################

SET Citation = {"PubMed", "Nat Commun. 2020 Mar 27;11(1):1620. doi: 10.1038/s41467-020-15562-9.", "32221306"}

SET PublicationType = "Research"
SET PublicationStatus = "Published"
SET Section = "Results"

SET Evidence = "Consistent with previous reports, 20mM NH4Cl and 100 nM bafilomycin A \
decreased entry of SARS-CoV S and VSV-G pseudovirions by over 99%, \
compared to no treatment control."

SET Custom_CellLine = "HEK293/hACE"
SET Virus_type = "pseudovirion"
SET concentration = "20 nM"
a(CHEBI:"ammonium chloride") neg a(MESH:"G protein, vesicular stomatitis virus")
a(CHEBI:"ammonium chloride") neg p(COVID:S)
UNSET concentration
SET concentration = "100 nM"
a(CHEBI:"bafilomycin A1") neg a(MESH:"G protein, vesicular stomatitis virus")
a(CHEBI:"bafilomycin A1") neg p(COVID:S)
UNSET concentration
UNSET Virus_type
UNSET Custom_CellLine

SET Evidence = "Inhibition of PIKfyve by apilimod significantly reduced entry of SARS- \
CoV S pseudovirions on 293/hACE2 cells in a dose dependent manner \
(Fig. 3b), whereas it had no effect on entry of VSV-G pseudovirions, \
which occurs in early endosomes."

SET Custom_CellLine = "HEK293/hACE"
a(PUBCHEM:10173277) neg p(HGNC:PIKFYVE)
SET Virus_type = "pseudovirion"
a(PUBCHEM:10173277) neg p(COVID:S)
a(PUBCHEM:10173277) cnc a(MESH:"G protein, vesicular stomatitis virus")
UNSET Virus_type
UNSET Custom_CellLine

SET Evidence = "Moreover, infection of live MHV on 17Cl.1 cells was also strongly \
inhibited by apilimod treatment (Fig. 3c)."

SET Custom_CellLine = "17cl1"
a(PUBCHEM:10173277) neg a(MESH:"Murine hepatitis virus")
UNSET Custom_CellLine

SET Evidence = "As expected, apilimod treatment inhibited entry of SARS-CoV-2 S \
pseudovirions in a dose dependent manner (Fig. 3d)"

a(PUBCHEM:10173277) neg a(TAX:"Severe acute respiratory syndrome coronavirus 2")

SET Evidence = "While blocking TPC2 activity by tetrandrine, an inhibitor for TPC237, \
decreased entry of SARS-CoV-2 S pseudovirions (Fig. 3f), treatment of \
cells with 130, a TRPML1 inhibitor, had no effect (Supplementary Fig. \
1), indicating that TPC2, not TRPML1, is important for SARS-CoV-2 \
entry."

a(CHEBI:"(+)-Tetrandrine") neg act(p(MGI:Tpcn2))
SET Virus_type = "pseudovirion"
a(CHEBI:"(+)-Tetrandrine") neg a(TAX:"Severe acute respiratory syndrome coronavirus 2")
UNSET Virus_type

SET Evidence = "E64D treatment of 293/hACE2 cells reduced entry of SARS-CoV-2 S \
pseudovirions by 92.5%, indicating that at least one of cathepsins or \
calpain might be required for SARS-CoV-2 entry (Fig. 4a)."

SET Custom_CellLine = "HEK293/hACE"
a(CHEBI:aloxistatin) -| p(COVID:S)
UNSET Custom_CellLine

SET Evidence = "While cathepsin B inhibitor treatment did not show any marked effect \
on virus entry, cathepsin L inhibition treatment decreased entry of \
SARS-CoV-2 S pseudovirions into 293/hACE2 by over 76% (Fig. 4a), \
suggesting that cathepsin L should be essential for priming of SARS- \
CoV-2 S protein in lysosome for entry into 293/hACE2 cells."

SET Custom_CellLine = "HEK293/hACE"
a(PUBCHEM:16725315) -| a(TAX:"Severe acute respiratory syndrome coronavirus 2")
p(HGNC:CTSL, loc(GO:lysosome)) -- a(TAX:"Severe acute respiratory syndrome coronavirus 2")
UNSET Custom_CellLine

SET Evidence = "Consistent to our previous report23, addition of trypsin triggered \
syncytium formation on 293/hACE2 cells by SARS-CoV S protein after 4 h \
incubation (Fig. 4b, c)."

SET Custom_CellLine = "HEK293/hACE"
SET Treatment = "Trypsin"
p(COVID:S) -> a(MESH:"Giant Cells")
UNSET Treatment
UNSET Custom_CellLine

SET Evidence = "Of note, SARS-CoV-2, but not SARS-CoV, S proteins induced syncytia \
formation on 293/hACE2 cells even in the absence of trypsin (Fig. 4c), \
suggesting that SARS-CoV-2 S proteins could be triggered upon the \
receptor binding without exogenous protease priming or activation."

SET Custom_CellLine = "HEK293/hACE"
p(COVID:S) -> a(MESH:"Giant Cells")
UNSET Custom_CellLine

UNSET Citation
